{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:22:38Z","timestamp":1790212958477,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005203","name":"OeAD-GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P 27814-B22"],"award-info":[{"award-number":["P 27814-B22"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.parint.2020.102218","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T02:25:51Z","timestamp":1604111151000},"page":"102218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Leishmania amazonensis response to artemisinin and derivatives"],"prefix":"10.1016","volume":"80","author":[{"given":"Laura","family":"Mach\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"N\u00e1poles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Gille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianet","family":"Monzote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parint.2020.102218_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.parint.2020.102218_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2016.11.012","article-title":"Leishmania infections: molecular","volume":"57","author":"Akhoundi","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.parint.2020.102218_bb0015","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","author":"Haldar","year":"2011","journal-title":"Mol. Biol. Int."},{"key":"10.1016\/j.parint.2020.102218_bb0020","first-page":"26","article-title":"Limitations of current therapeutic options, possible drug targets and scope of natural products in control of leishmaniasis","volume":"18","author":"Tiwari","year":"2018","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.parint.2020.102218_bb0025","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"van Griensven","year":"2010","journal-title":"Lancet Inf. Dis."},{"key":"10.1016\/j.parint.2020.102218_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0005480","article-title":"The enemy within: targeting host\u2013parasite interaction for antileishmanial drug discovery","volume":"11","author":"Lamotte","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.parint.2020.102218_bb0035","first-page":"1","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.parint.2020.102218_bb0040","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.drudis.2009.05.008","article-title":"Progress in the development of peroxide-based anti-parasitic agents","volume":"14","author":"Muraleedharan","year":"2009","journal-title":"Drug Dis. Today"},{"key":"10.1016\/j.parint.2020.102218_bb0045","article-title":"Activation of artemisinin and heme degradation in Leishmania tarentolae promastigotes: a possible link","volume":"113737","author":"Geroldinger","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.parint.2020.102218_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.exppara.2013.10.007","article-title":"Essential oil from Chenopodium ambrosioides and main components: activity against Leishmania, their mitochondria and other microorganisms","volume":"136","author":"Monzote","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.parint.2020.102218_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23071680","article-title":"Activation of anthracene endoperoxides in Leishmania and impairment of mitochondrial functions","volume":"23","author":"Geroldinger","year":"2018","journal-title":"Mol."},{"key":"10.1016\/j.parint.2020.102218_bb0060","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1021\/jm030181q","article-title":"Structure-activity relationships of the antimalarial agent artemisinin. 8. Design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria","volume":"46","author":"Avery","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.parint.2020.102218_bb0065","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1128\/AAC.00298-15","article-title":"In vitro susceptibility of Leishmania infantum to artemisinin derivatives and selected trioxolanes","volume":"59","author":"Cortes","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2020.102218_bb0070","first-page":"903","article-title":"In vitro evaluation of antileishmanial activity and toxicity of artemether with focus on its apoptotic effect","volume":"12","author":"Ebrahimisadr","year":"2013","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.parint.2020.102218_bb0075","first-page":"258","article-title":"Evaluation of apoptotic and Antileishmanial activities of artemisinin on promastigotes and BALB\/C mice infected with Leishmania major","volume":"10","author":"Ghaffarifar","year":"2015","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.parint.2020.102218_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S0031182000074758","article-title":"Effects of qinghaosu (artemisinin) and its derivatives on experimental cutaneous leishmaniasis","volume":"106","author":"Yang","year":"1993","journal-title":"Parasitology"},{"key":"10.1016\/j.parint.2020.102218_bb0085","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1099\/jmm.0.47364-0","article-title":"Artemisinin triggers induction of cell-cycle arrest and apoptosis in Leishmania donovani promastigotes","volume":"56","author":"Sen","year":"2007","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.parint.2020.102218_bb0090","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3109\/10715762.2010.498475","article-title":"Iron enhances generation of free radicals by artemisinin causing a caspase-independent, apoptotic death in Leishmania donovani promastigotes","volume":"44","author":"Sen","year":"2010","journal-title":"Free Rad. Res."},{"key":"10.1016\/j.parint.2020.102218_bb0095","article-title":"In vitro and in vivo studies of antileishmanial effect of artemether on Leishmania infantum","volume":"6","author":"Dehkordi","year":"2013","journal-title":"Jundish. J. Microbiol."},{"key":"10.1016\/j.parint.2020.102218_bb0100","first-page":"1","article-title":"Leishmaniasis: a review","volume":"6","author":"Torres","year":"2017","journal-title":"F1000 Fac. Rev."},{"key":"10.1016\/j.parint.2020.102218_bb0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijantimicag.2010.03.008","article-title":"Efficacy of artemisinin in experimental visceral leishmaniasis","volume":"36","author":"Sen","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.parint.2020.102218_bb0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.taap.2009.08.001","article-title":"Toxic effects of essential oil from Chenopodium ambrosioides and its major ingredients on mitochondria","volume":"240","author":"Monzote","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.parint.2020.102218_bb0115","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/AAC.43.5.1234","article-title":"Selective effect of 2\u2032,6\u2032 -dihydroxy-4\u2019methoxychalcone isolated from Piper aduncum on Leishmania amazonensis","volume":"43","author":"Caio","year":"1999","journal-title":"Antimicrob. Antimicrob. Agents. Chemother."},{"key":"10.1016\/j.parint.2020.102218_bb0120","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1128\/AAC.45.5.1349-1354.2001","article-title":"Antileishmanial activity of an indole alkaloid from Peschiera australis","volume":"45","author":"Delorenzi","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2020.102218_bb0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-1759(93)90088-O","article-title":"An improve MTT assay","volume":"157","author":"Sladowski","year":"1993","journal-title":"J. Immunol. Met."},{"key":"10.1016\/j.parint.2020.102218_bb0130","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1824","article-title":"Opportunities and challenges in antiparasitic drug discovery","volume":"4","author":"Pink","year":"2005","journal-title":"Nat. Rev. Drug. Dis."},{"key":"10.1016\/j.parint.2020.102218_bb0135","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","article-title":"Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice","volume":"39","author":"Buffet","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2020.102218_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms18061296","article-title":"Cutaneous manifestations of human and murine leishmaniasis","volume":"18","author":"Scorza","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.parint.2020.102218_bb0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: an update of current pharmacotherapy","volume":"14","author":"Sundar","year":"2013","journal-title":"Exp. Opi. Pharm."},{"key":"10.1016\/j.parint.2020.102218_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004545","article-title":"Old World cutaneous leishmaniasis and refugee crises in the middle East and North Africa","volume":"10","author":"Du","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.parint.2020.102218_bb0155","first-page":"1","article-title":"Biomarkers of cutaneous leishmaniasis","volume":"8","author":"Bahrami","year":"2018","journal-title":"Front. Cell. Inf. Micro."},{"key":"10.1016\/j.parint.2020.102218_bb0160","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0035-9203(93)90030-T","article-title":"The clinical and immunological spectrum of American cutaneous leishmaniasis","volume":"87","author":"Convit","year":"1993","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2020.102218_bb0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcp.2017.02.023","article-title":"Mechanism of ascaridole activation in Leishmania","volume":"132","author":"Geroldinger","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.parint.2020.102218_bb0170","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0036-46652011000300003","article-title":"In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against Leishmania donovani in BALB\/c mice","volume":"53","author":"Mutiso","year":"2011","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.parint.2020.102218_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ange.200604697","article-title":"A common \u2018free iron\u2019 dependent machnism of activation among diverse antimalarial endoperoxide structures","volume":"119","author":"Stocks","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.parint.2020.102218_bb0180","first-page":"1","article-title":"The leishmanicidal activity of artemisinin is mediated by cleavage of the endoperoxide bridge and mitochondrial dysfunction","author":"De Sarkar","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.parint.2020.102218_bb0185","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1080\/10717544.2018.1494222","article-title":"Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell","volume":"25","author":"Dar","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.parint.2020.102218_bb0190","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.parint.2020.102218_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135556","article-title":"Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning","volume":"10","author":"Kaiser","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.parint.2020.102218_bb0200","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1747-0285.2006.00391.x","article-title":"Searching for new antimalarial therapeutics amongst known drugs","volume":"67","author":"Weisman","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.parint.2020.102218_bb0205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0273-2300(05)80052-2","article-title":"Extrapolation of animal toxicity to humans: interspecies comparisons in drug development","volume":"12","author":"Voisin","year":"1990","journal-title":"Reg. Tox. Pharmacol."},{"key":"10.1016\/j.parint.2020.102218_bb0210","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1128\/mr.60.2.301-315.1996","article-title":"Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy","volume":"60","author":"Meshnick","year":"1996","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.parint.2020.102218_bb0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.parint.2020.102218_bb0220","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Dis. Today. Technol."},{"key":"10.1016\/j.parint.2020.102218_bb0225","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2016.11.012","article-title":"Artemisinin and its derivatives in treating protozoan infections beyond malaria","volume":"117","author":"Loo","year":"2017","journal-title":"Pharmacol. Res."}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576920301689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576920301689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:29:14Z","timestamp":1778606954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576920301689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":45,"alternative-id":["S1383576920301689"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2020.102218","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leishmania amazonensis response to artemisinin and derivatives","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2020.102218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102218"}}